Log in
ASX:RVA

REVA Medical Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
REVA Medical, Inc., a medical device company, focuses on the development and commercialization of polymer-based bioresorbable products for vascular applications. The company offers Fantom Encore, a bioresorbable vascular scaffold for the treatment of coronary artery disease; and MOTIV bioresorbable vascular scaffold for the treatment of below-the-knee peripheral artery disease. It sells Fantom Encore in Germany, Switzerland, Austria, the Netherlands, Belgium, Luxembourg, Italy, and Turkey. The company was formerly known as MD3, Inc. and changed its name to REVA Medical, Inc. in March 2002. REVA Medical, Inc. was founded in 1998 and is headquartered in San Diego, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.50 out of 5 stars


Industry, Sector and Symbol

Industry Medical Devices
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-858-9663000
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

Receive RVA News and Ratings via Email

Sign-up to receive the latest news and ratings for RVA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











REVA Medical (ASX:RVA) Frequently Asked Questions

What stocks does MarketBeat like better than REVA Medical?

Wall Street analysts have given REVA Medical a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but REVA Medical wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were REVA Medical's earnings last quarter?

REVA Medical Inc (ASX:RVA) announced its quarterly earnings data on Tuesday, August, 7th. The company reported $0.61 earnings per share for the quarter.
View REVA Medical's earnings history
.

Who are some of REVA Medical's key competitors?

Who are REVA Medical's key executives?

REVA Medical's management team includes the following people:
  • Ms. Regina E. Groves, CEO & Director (Age 61)
  • Mr. Robert B. Stockman, Co-Founder & Director (Age 65)
  • Mr. Jeffrey A. Anderson, Sr. VP of Clinical & Regulatory Affairs (Age 52)
  • Ms. Leigh F. Elkolli, CFO, Principal Accounting Officer, Corp. Sec. & Corp. Controller (Age 47)
  • Ms. Jessica Earley, VP of Operations & Product Devel.

What is REVA Medical's stock symbol?

REVA Medical trades on the ASX under the ticker symbol "RVA."

How big of a company is REVA Medical?

REVA Medical has a market capitalization of $0.00.

What is REVA Medical's official website?

The official website for REVA Medical is www.teamreva.com.

How can I contact REVA Medical?

REVA Medical's mailing address is 5751 Copley Dr, SAN DIEGO, CA 92111-7911, United States. The company can be reached via phone at +1-858-9663000.

This page was last updated on 11/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.